Dan M. Watkins

Dan M. Watkins

Fundador en
Mercury Partners Management LLC
.
Health Technology
Technology Services
Consumer Services

Perfil

Dan M.
Watkins
was the founder of Nanospectra Biosciences, Inc. (2002) serving as Director, VizionWare, Inc. (2004), Mercury Partners Management LLC (2005) serving as Venture Advisor, and Mercury Data Science, Inc. (2018) serving as Director.
Dr. Watkins was also the founder of DNAtrix, Inc.,Benson Hill Holdings, Inc.,Rice Alliance Austin,Courier Therapeutics, Inc...
Dr. Watkins was Chief Executive Officer at Pelagos Pharmaceuticals, Inc. since 2020.
Dr. Watkins is Director at GlycosBio, Inc., Sinopsys Surgical, Inc., Aclaris Life Sciences, Inc., BioHouston, Inc., Olea Networks, Inc., and Secretary & Director at Resonant Therapeutics, Inc. Dr. Watkins was Director at Vertos Medical, Inc., cGate Health, Inc., Deep Imaging Technologies, Inc., Marval Pharma Ltd., Illumitex, Inc., and Swift Biosciences, Inc. Dr. Watkins completed undergraduate studies at William Marsh Rice University and graduate and doctorate degrees at Carnegie Mellon University.

Cargos activos de Dan M. Watkins

EmpresasCargoInicio
Fundador 01/01/2005
Fundador -
Director/Miembro de la Junta -
Director/Miembro de la Junta -
Director/Miembro de la Junta -
Director/Miembro de la Junta -
Director/Miembro de la Junta -
Director/Miembro de la Junta -
Fundador -

Antiguos cargos conocidos de Dan M. Watkins.

EmpresasCargoFin
░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░ -
░░░░░░ ░░░░ ░░░░░░░░░ ░░░░ ░░░░░░░░ -
░░░░░░░░░░░ ░░░░ ░░░░░░░░ -
░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ -
░░░░ ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ -
Ver el detalle de la experiencia de Dan M. Watkins.

Formación de Dan M. Watkins.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

49

Relaciones de 1er grado

22

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas22

Consumer Services

Health Technology

Consumer Durables

Health Technology

Electronic Technology

Technology Services

Health Technology

Technology Services

Health Services

Process Industries

Consumer Services

Health Technology

Commercial Services

Finance

Health Technology

Electronic Technology

Health Technology

Health Technology

Technology Services

Commercial Services

Health Technology

Technology Services

-40%: Ampliación de plazo extraordinaria
d
:
:
APROVECHAR LA PROMOCIÓN